While you're enjoying the warm June sun, our analysts are busy uncovering market opportunities. One company that has caught their attention is Delivra Health Brands (TSXV: DHB), a Canadian player in two booming markets: sleep aids (think Dream Water®) and pain relief topicals (LivRelief™).
However, the question remains: is DHB capitalizing on this market growth?
Our analysts' recent report offers a deep dive into DHB's performance, analyzing their impressive 29% stock surge and 31% year-over-year revenue growth. They also explore Delivra's distribution network, encompassing major retailers like Walmart and Shoppers Drug Mart, and unpack their current product portfolio.
Our analysts are encouraged by DHB's improving profitability and upcoming catalysts like exciting new product launches (including Dream Water® gummies!) and potential expansion into the US market.
Find out more in our full report! We dissect analyst estimates, future projections, and the overall market potential for Delivra Health Brands.
Link to the report: https://www.researchfrc.com/content/reports/post/92/record-revenue-and-new-products-boost-market-sentiment
*FRC provides issuer-paid coverage.
*Past performance is not indicative of future results.